间歇性跛行或慢性肢体威胁性缺血患者腔内血运重建的危险因素分析与长期结局
该回顾性队列研究纳入2011年1月至2020年12月接受经皮腔内血管成形术/支架置入的640例外周动脉疾病患者(间歇性跛行243例,慢性肢体威胁性缺血377例)。慢性肢体威胁性缺血组30天再入院率、30天内急诊再手术率及同期住院死亡率均显著高于间歇性跛行组,且总生存率和无截肢生存率显著更低;Cox多因素分析显示慢性肢体威胁性缺血是全因死亡和截肢的强预测因素(HR 2.33和HR 14.92)。
要点
- 慢性肢体威胁性缺血组30天再入院率18.8% vs 间歇性跛行组6.5%,P<0.001。
- 慢性肢体威胁性缺血组总生存率和无截肢生存率均显著低于间歇性跛行组(P<0.0001)。
- 间歇性跛行患者血运重建后5年截肢风险低于1%。
核心结论
- 间歇性跛行和慢性肢体威胁性缺血患者均表现为下肢动脉粥样硬化闭塞性疾病,但临床结局可能不同,两组均有显著死亡发生。
- 间歇性跛行患者血运重建后5年截肢风险低于1%。
研究设计与样本
- 回顾性队列研究,数据前瞻性收集自临床数据分析与报告系统、科室数据库和临床管理系统。
- 纳入2011年1月至2020年12月期间因外周动脉疾病接受腔内手术的所有患者,共640例(间歇性跛行243例,慢性肢体威胁性缺血377例)。
- 主要结局为总生存率和无截肢生存率,采用Cox模型确定预测因素。
主要发现
- 慢性肢体威胁性缺血组30天再入院率18.8% vs 间歇性跛行组6.5%,P<0.001。
- 慢性肢体威胁性缺血组30天内急诊再手术率3.4% vs 间歇性跛行组0%,P=0.002。
- 慢性肢体威胁性缺血组同期住院死亡率2.7% vs 间歇性跛行组0%,P=0.008。
- 慢性肢体威胁性缺血组总生存率和无截肢生存率均显著低于间歇性跛行组(P<0.0001和P<0.0001)。
- Cox多因素分析显示,慢性肢体威胁性缺血是全因死亡和截肢的强预测因素(HR 2.33和HR 14.92)。
关键数值与推荐
- 在慢性肢体威胁性缺血患者中,慢性肾脏病是死亡和截肢的独立预测因素(HR 1.66和HR 2.36)。
- 在慢性肢体威胁性缺血患者中,吸烟和缺血性心脏病也是死亡的独立预测因素(HR 2.06和HR 2.43)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The aim of this study is to review long-term outcome and identify risk factors for patients with peripheral arterial disease (PAD) with percutaneous transluminal angioplasty/stent as a primary treatment strategy for intermittent claudication (IC) or chronic limb-threatening ischemia (CLTI). METHODS: A retrospective cohort study with data collected prospectively from Clinical Data Analysis and Reporting System, departmental database, and Clinical Management System. All patients who underwent endovascular procedures for PAD between January 2011 and December 2020 were identified. The primary outcomes are overall survival and amputation-free survival. Predictive factors for OS and AFS were determined using Cox Model. RESULTS: A total number of 640 patients with PAD (IC, n = 243; CLTI, n = 377) underwent endovascular percutaneous transluminal angioplasty/stenting for PAD from January 2011 to December 2020. Patients with CLTI had a significantly higher 30 days readmission rate (18.8% vs. 6.5%, P < 0.001), emergency reoperation within 30 days (3.4% vs. 0%, P = 0.002), and death within same admission (2.7% vs. 0%, P = 0.008) compared to IC patients. The overall survival and amputation-free survival rates were significantly lower in CLTI patients (P < 0.0001 and P < 0.0001, respectively). On Cox multivariate analysis, CLTI was strongly predictive of all-cause mortality and amputation (hazard ratio [HR] 2.33 and HR 14.92, respectively). In patients with CLTI, chronic kidney disease was an independent predictor of mortality and amputation (HR 1.66 and HR 2.36, respectively). Smoking and ischemic heart disease were also independent predictors of mortality in this subgroup (HR 2.06 and HR 2.43, respectively). CONCLUSIONS: Although patients with IC and CLTI both manifest from atherosclerotic occlusive disease of the lower limb arteries, these patients may have different clinical outcomes with significant mortality occurred in both IC and CLTI groups. In patients with IC, the risk of amputation was less than 1% at 5 years following revascularization.
引用
- Fung V, Chan YC, Cheung GC, et al. Risk Factor Analysis and Long-Term Outcomes in Patients with Endovascular Revascularization for Intermittent Claudication or Chronic Limb-Threatening Ischemia. Ann Vasc Surg. 2022. PMID: 36162626. doi:10.1016/j.avsg.2022.09.038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。